Dextromethorphan Market Share

  • Report ID: 4078
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Dextromethorphan Market Share

North American Market Forecast   

The North American dextromethorphan market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the increasing cases of bronchitis and bronchial asthma in the region. According to the data from the Centers for Disease Control and Prevention (CDC), 46.3 individuals out of every 100,000 population die due to chronic lower respiratory diseases in the U.S. Furthermore, as per a research paper by the National Library of Medicine, it is estimated that 5% of the population of North America reports an episode of acute bronchitis every year, accounting for more than 10 million hospital visits. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies are also anticipated to contribute to market growth in the region. In addition, the region's expanding healthcare industry and rising healthcare expenditure are also anticipated to expand the size of the market during the forecast period.

APAC Market Statistics

On the other hand, the market in the Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing cases of asthma, bronchitis, and cough along with the rising geriatric population in the region. Also, the high level of pollution and recent urbanization are other factors that are anticipated to fuel revenue generation of the market in the region in the upcoming years.

Research Nester
Dextromethorphan Market Share
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4078
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of dextromethorphan is evaluated at USD 413.38 Million.

The dextromethorphan market size was over USD 396.34 Million in 2023 and is expected to exceed USD 685.12 Million by the end of 2036, witnessing over 4.3% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of severe cough and other diseases is estimated to boost the market growth.

North America is projected to hold largest industry share by 2036, due to increasing cases of bronchitis and bronchial asthma in the region.

AstraZeneca PLC, FibroGen, Inc., Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Sunovion Pharmaceuticals Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample